Firm Invitations Traders, Analysts, and Advisors to Attend Its Actual-Time, Interactive UST Platform and Agrochem Asset Acquisition Replace, Adopted by a Q&A Session, on Wednesday, July 21, 2021
SOUTH EASTON, MA / ACCESSWIRE / July 20, 2021 / Strain BioSciences, Inc. (OTCQB:PBIO) (“PBI” and the “Firm”), a pacesetter within the improvement and sale of progressive, broadly enabling, pressure-based devices, consumables, and providers to the worldwide life sciences, agriculture, meals & beverage, and different key industries, at present introduced the Firm’s participation within the July 21st Rising Progress Convention. This real-time, interactive investor convention will function 11 corporations, presenting for 30-45 minutes every. PBI’s President and CEO, Mr. Richard T. Schumacher, has been requested to steer off the convention and to increase on the Firm’s lately reported long-term CBD stability and Astaxanthin processing breakthroughs utilizing its Extremely Shear Expertise™ (UST™) nanoemulsification platform. Mr. Schumacher will even current an replace on its impending acquisition of property of a worldwide eco-friendly agrochemicals firm. Mr. Schumacher’s presentation info is under:
DATE: Wednesday, July 21, 2021 (9:30 am EDT)
PRESENTATION: Video Webcast
Highlights of Current Press Launch on UST Nanoemulsification of Astaxanthin
Astaxanthin is taken into account one of many world’s most potent antioxidants
Purposes span pharmaceutical, nutraceutical, beauty, meals & beverage, and animal feed industries
As an antioxidant, it’s stronger than Vitamin C (6,000x), Coenzyme Q (800x), and Vitamin E (100x)
It’s plant oil primarily based, which makes it tough to soak up by people/animals when taken as a complement
UST-processed nanoemulsions of Astaxanthin oil would considerably enhance its water solubility and bioavailability, lengthen its shelf-life, permit for extra exact dosing, and save prices for producers/customers
The worldwide marketplace for Astaxanthin was estimated to be $1 billion in 2019
Highlights of Current Press Launch on Achievement of Over One Yr Shelf-life of UST Nanoemulsified CBD Oil
Many nutritional vitamins and different dietary dietary supplements are oil-based and thus tough for people/animals to soak up
Science has proven that that oil-based merchandise processed to the nano-level (nanoemulsions) are considerably extra water soluble, bioavailable, and long-term secure
True long-term secure nanoemulsions are tough to make, particularly at giant, business scale
UST processed nanoemulsions of CBD oil in water have been proven to soar previous PBI’s one-year stability purpose, with over 14 months of long-term stability
Such rock-solid stability opens up explosive progress potential for UST-processed CBD-infused drinks
The CBD market is anticipated to develop to roughly $13 Billion by 2028
About EmergingGrowth.com & the Rising Progress Convention
Based in 2009, EmergingGrowth.com shortly turned a number one, impartial small cap media portal. Through the years, it has developed an in depth historical past of offering unparalleled content material in figuring out rising progress corporations and markets that may be neglected by the funding group.
The Rising Progress Convention has confirmed to be an efficient means for publicly traded corporations to current and talk new merchandise, providers, and different main bulletins to the funding group in an efficient and time environment friendly method. The viewers contains doubtlessly hundreds of particular person and institutional buyers, in addition to funding advisors and analysts.
About Strain BioSciences, Inc.
Strain BioSciences, Inc. (OTCQB:PBIO) is a pacesetter within the improvement and sale of progressive, broadly enabling, pressure-based options for the worldwide life sciences and different industries. Our merchandise are primarily based on the distinctive properties of each fixed (i.e., static) and alternating (i.e., strain biking expertise, or PCT) hydrostatic strain. PCT is a patented enabling expertise platform that makes use of alternating cycles of hydrostatic strain between ambient and ultra-high ranges to regulate bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Ourprimary focus is the event of PCT-based merchandise for biomarker and goal discovery, drug design and improvement, biotherapeutics characterization and high quality management, soil & plant biology, forensics, and counter-bioterror purposes. Moreover, main new market alternatives have emerged in the usage of our pressure-based applied sciences within the following areas: (1) the usage of our lately acquired, patented expertise from BaroFold, Inc. (the “BaroFold” expertise) to permit entry into the bio-pharma contract providers sector, and (2) the usage of our recently-patented, scalable, high-efficiency, pressure-based Extremely Shear Expertise (“UST”) platform to (i) create secure nanoemulsions of in any other case immiscible fluids (e.g.,oils and water) and to (ii) put together increased high quality, homogenized, prolonged shelf-life or room temperature secure low-acid liquid meals that can’t be successfully preserved utilizing current non-thermal applied sciences.
Ahead Wanting Statements
This press launch incorporates forward-looking statements. These statements relate to future occasions or our future monetary efficiency and contain recognized and unknown dangers, uncertainties and different components that will trigger our or our business’s precise outcomes, ranges of exercise, efficiency, or achievements to be materially totally different from any future outcomes, ranges of exercise, efficiency or achievements expressed, implied, or inferred by these forward-looking statements. In some instances, youcan establish forward-looking statements by terminology comparable to “could,” “will,” “ought to,””may,””would,” “expects,” “plans,” “intends,””anticipates,” “believes,” estimates,””predicts,” “initiatives,””potential” or “proceed” or the destructive of such phrases and different comparable terminology. These statements are solely predictions primarily based on our present expectations and projections about future occasions. You shouldn’t placeundue reliance on these statements. In evaluating these statements, you need to particularly think about numerous components. Precise occasions or outcomes could differ materially. These and different components could trigger our precise outcomes to vary materially fromany forward-looking assertion. These dangers, uncertainties, and different components embrace, however aren’t restricted to, the dangers and uncertainties mentioned below the heading “Danger Elements” within the Firm’s Annual Report on Type 10-Okay for the yr ended December 31, 2020, and different reviews filed by the Firm now and again with the SEC. The Firm undertakes no obligation to replace any of the knowledge included on this launch, besides as in any other case required by legislation.
For extra details about PBI and this press launch, please click on on the next web site hyperlink:
Please go to us on Fb, LinkedIn, and Twitter.
Richard T. Schumacher, President & CEO (508) 230-1828 (T)
Jeffrey N. Peterson, Chairman of the Board (650) 812-8121 (T)
SOURCE: Strain BioSciences Inc.
View supply model on accesswire.com: